Design, synthesis and biological activity of novel 2,3,4,5-tetra-substituted thiophene derivatives as PI3Kα inhibitors with potent antitumor activity

Eur J Med Chem. 2020 Jul 1:197:112309. doi: 10.1016/j.ejmech.2020.112309. Epub 2020 Apr 19.

Abstract

Using a rational design strategy for isoform-selective inhibition of PI3Kα, two series of novel 2,3,4,5-tetra-substituted thiophene derivatives containing either diaryl urea or N-Acylarylhydrazone scaffold were designed and synthesized. The most promising compound 12k was demonstrated to bear nanomolar PI3Kα inhibitory potency with 12, 28, 30, 196-fold selectivity against isoforms β, γ, δ and mTOR. Besides, it also showed good developability profiles in cell-based proliferation against a panel of human tumor cells as well as ADME assays. We herein report on their design, synthesis, SAR and potential developability properties.

Keywords: 2,3,4,5-Tetra-substituted thiophene derivatives; Antiproliferative activities; PI3Kα; Synthesis.

MeSH terms

  • Antineoplastic Agents / chemical synthesis
  • Antineoplastic Agents / metabolism
  • Antineoplastic Agents / pharmacokinetics
  • Antineoplastic Agents / pharmacology*
  • Binding Sites
  • Cell Line, Tumor
  • Cell Proliferation / drug effects
  • Drug Design
  • Drug Screening Assays, Antitumor
  • Humans
  • Molecular Docking Simulation
  • Molecular Structure
  • Phosphatidylinositol 3-Kinases / chemistry
  • Phosphatidylinositol 3-Kinases / metabolism
  • Phosphoinositide-3 Kinase Inhibitors / chemical synthesis
  • Phosphoinositide-3 Kinase Inhibitors / metabolism
  • Phosphoinositide-3 Kinase Inhibitors / pharmacokinetics
  • Phosphoinositide-3 Kinase Inhibitors / pharmacology*
  • Protein Binding
  • Structure-Activity Relationship
  • TOR Serine-Threonine Kinases / antagonists & inhibitors
  • Thiophenes / chemical synthesis
  • Thiophenes / metabolism
  • Thiophenes / pharmacokinetics
  • Thiophenes / pharmacology*

Substances

  • Antineoplastic Agents
  • Phosphoinositide-3 Kinase Inhibitors
  • Thiophenes
  • MTOR protein, human
  • TOR Serine-Threonine Kinases